Clinical trial
Follow-up Study of Chinese Medicine for the Treatment of Chronic Atrophic Gastritis Based on Histological Evaluation
NCT02955134 is registered in ClinicalTrials.gov with Wangjing Hospital, China Academy of Chinese Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Follow-up Study of Chinese Medicine for the Treatment of Chronic Atrophic Gastritis Based on Histological Evaluation
- Lead sponsor
- Wangjing Hospital, China Academy of Chinese Medical Sciences
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 12, 2018
- Completion date
- November 30, 2021
- Enrollment
- 468 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.
chronic atrophic gastritis